---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-26-000115"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2026-07-30T20:05:40+00:00"
generated_at: "2026-07-30T20:06:34.322988+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# AIP completes acquisition of Avanos for $1.272B; stockholders receive $25.00/share cash

## Summary
- Deal valued at ~$1.272B; Avanos stockholders get $25.00 per share in cash.
- Avanos common stock delisted from NYSE; company becomes private.
- New board: David Pacitti CEO, Scott Galovan CFO, John Fischer General Counsel.
- Credit agreement: $675M term loan, $100M DDTL, $100M revolver, matures 2033.
- Prior directors resigned; Joel Rotroff (AIP) initially appointed then replaced.

## SEC filing metadata
- accession: 0001606498-26-000115
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2026-07-30T20:05:40+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/0001606498-26-000115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649826000115/avns-20260727.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-26-000115
- JSON: https://secwatch.observer/filing/0001606498-26-000115.json
- Plain text: https://secwatch.observer/filing/0001606498-26-000115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.